ANTITRUST NEWS: FTC touts Caremark settlement will drive down patient costs, increase ...

The FTC settled with Caremark (CVS Health subsidiary), a major pharmacy benefit manager, requiring business practice changes including insulin price caps, increased transparency, and fair treatment of community pharmacies. The settlement locks in $8.5 billion in consumer savings over 10 years with potential additional $4.5 billion from point-of-sale rebates.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.